IPF's effects are relentless, says columnist Charlene Marshall, who faced various knee surgery complications because of her lung disease.

As his birthday approaches, columnist Sam Kirton shares what has transpired in his life since he began this latest trip ...

Nerandomilast demonstrated it was able to outperform a placebo at improving lung function in IPF or preventing its decline ...

A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...

Pulmonary Fibrosis Awareness Month may be coming to a close, but it's important to keep the momentum going, columnist Sam Kirton says.

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Avalyn Pharma has started a Phase 2b clinical trial testing the safety and efficacy of AP01, its investigational inhaled formulation of pirfenidone, in adults with progressive pulmonary fibrosis (PF).